San Juan City Hospital Hematology and Medical Oncology

Topics

• Multiple Myeloma Research and Treatments 91
• CAR-T cell therapy research 25
• Hematopoietic Stem Cell Transplantation 17
• Lymphoma Diagnosis and Treatment 5
• Viral-associated cancers and disorders 4
• Chronic Lymphocytic Leukemia Research 3
• Acute Lymphoblastic Leukemia research 2
• Acute Myeloid Leukemia Research 2
• Amyloidosis: Diagnosis, Treatment, Outcomes 2
• Body Contouring and Surgery 1
• Bone health and treatments 1
• Bone Metabolism and Diseases 1

Most cited

1. Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.

   Blood · 2025 · 135 citations · Melissa Alsina

2. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

   The New England journal of medicine · 2022 · 422 citations · Melissa Alsina

3. Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 271 citations · Melissa Alsina

4. Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 48 citations · Melissa Alsina

5. The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.

   Journal of hematology & oncology · 2023 · 128 citations · Melissa Alsina

6. Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.

   Blood cancer journal · 2023 · 117 citations ·